TOPICS

Category: Psoriasis

Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study

J Clin Aesthet Dermatol. 2020;13(5):12–18 by Dharm S. Patel, PhD; Karen A. Veverka, PhD; Jes B. Hansen, PhD;  Paul S. Yamauchi, MD; Javier Alonso-Llamazares, MD; and Mark Lebwohl, MD Drs. Patel and Veverka are with LEO Pharma in Madison, New Jersey. Dr. Hansen is with LEO Pharma in Ballerup, Denmark. Dr. Yamauchi is with the

CONTINUE READING »

Topical Corticosteroid Therapy for Psoriasis—A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification

J Clin Aesthet Dermatol. 2020;13(2):22–29 by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada and Touro University Nevada in Henderson, Nevada. FUNDING: No funding was provided for this review. DISCLOSURES: Dr. Del Rosso has served as a consultant, speaker, and research investigator for

CONTINUE READING »

Innovations in Psoriasis Management: Based on Selected Presentations from Music City SCALE Symposium for Cosmetic Advances & Laser Education

Innovations in Psoriasis Management Based on Selected Presentations from Music City SCALE Symposium for Cosmetic Advances & Laser Education May 9–11, 2019, Nashville, Tennessee by Jo Ann LeQuang Owner, LeQ Medical, Angleton, Texas; Director of Scientific Communications, NEMA Research, Inc., Naples, Florida; Founding Director, No Baby Blisters, Colorado Springs, Colorado. J Clin Aesthet Dermatol 2019;12(12):S8–S19 Based on

CONTINUE READING »